Skip to main content
×
×
Home

Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis

  • H. G. H. Tamminga (a1) (a2), L. Reneman (a1) (a3) (a4), H. M. Huizenga (a2) (a3) (a5) and H. M. Geurts (a2) (a3) (a5)
Abstract

Attention-deficit/hyperactivity disorder (ADHD) in childhood and adulthood is often treated with the psychostimulant methylphenidate (MPH). However, it is unknown whether cognitive effects of MPH depend on age in individuals with ADHD, while animal studies have suggested age-related effects. In this meta-analysis, we first determined the effects of MPH on response inhibition, working memory and sustained attention, but our main goal was to examine whether these effects are moderated by age. A systematic literature search using PubMed, PsycINFO, Web of Science and MEDLINE for double-blind, placebo-controlled studies with MPH resulted in 25 studies on response inhibition (n = 775), 13 studies on working memory (n = 559) and 29 studies on sustained attention (n = 956) (mean age range 4.8–50.1 years). The effects of MPH on response inhibition [effect size (ES) = 0.40, p < 0.0001, 95% confidence interval (CI) 0.22–0.58], working memory (ES = 0.24, p = 0.053, 95% CI 0.00–0.48) and sustained attention (ES = 0.42, p < 0.0001, 95% CI 26–0.59) were small to moderate. No linear or quadratic age-dependencies were observed, indicating that effects of MPH on executive functions are independent of age in children and adults with ADHD. However, adolescent studies are lacking and needed to conclude a lack of an age-dependency across the lifespan.

Copyright
Corresponding author
*Address for correspondence: H. G. H. Tamminga, Ph.D., Department of Psychology, University of Amsterdam, Weesperplein 4, 1018 XA Amsterdam, The Netherlands. (Email: g.h.tamminga@amc.nl)
References
Hide All
Agay N, Yechiam E, Carmel Z, Levkovitz Y (2010). Non-specific effects of methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults. Psychopharmacology 210, 511519.
Agay N, Yechiam E, Carmel Z, Levkovitz Y (2014). Methylphenidate enhances cognitive performance with poor baseline capacities regardless of attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology 34, 261265.
American Academy of Pediatrics (2001). Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 108, 10331044.
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th edn. APA: Washington, DC.
Andersen SL (2005). Stimulants and the developing brain. Trends in Pharmacological Sciences 26, 237243.
Aron RA, Dowson JH, Sahakian BJ, Robbins TW (2003). Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biological Psychiatry 54, 14651468.
Barkley RA, Fischer M, Newby RF, Breen MJ (1988). Development of a multimethod clinical protocol for assessing stimulant drug response in children with attention deficit disorder. Journal of Clinical Child Psychology 17, 1424.
Barkley RA, Fischer M, Smallish L, Fletcher K (2002). The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. Journal of Abnormal Psychology 111, 279289.
Barkley RA, Murphy KR, O'Connell T, Connor DF (2005). Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder. Journal of Safety Research 36, 121131.
Bedard A, Ickowicz A, Logan GD, Hogg-Johnson S, Schachar R, Tannock R (2003). Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication. Journal of Abnormal Child Psychology 31, 315327.
Bedard A, Tannock R (2008). Anxiety, methylphenidate response, and working memory in children with ADHD. Journal of Attention Disorders 11, 546557.
Biederman J, Mick E, Fried R, Wilner N, Spencer TJ, Faraone SV (2011). Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD. European Neuropsychopharmacology 21, 508515.
Bizot C, Chenault N, Houzé B, Herpin A, David S, Pothion S, Trovero F (2007). Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats. Psychopharmacology 193, 215223.
Blakemore S, Choudhury S (2006). Development of the adolescent brain: implications for executive function and social cognition. Journal of Child Psychology and Psychiatry 47, 296312.
Blum NJ, Awad AF, Clarke AT, Power TJ (2011). Effect of osmotic-release oral system methylphenidate on different domains of attention and executive functioning in children with attention-deficit-hyperactivity disorder. Developmental Medicine and Child Neurology 53, 843849.
Bolanos CA, Glatt SJ, Jackson D (1998). Subsensitivity to dopaminergic drugs in periadolescent rats: a behavioural and neurochemical analysis. Developmental Brain Research 111, 2533.
Boonstra AM, Kooij JJS, Oosterlaan J, Sergeant JA, Buitelaar JK (2005). Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD? Journal of Clinical and Experimental Neuropsychology 27, 278298.
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009). Introduction to Meta-Analysis, pp. 225238. John Wiley & Sons: Chichester, UK.
Bouffard R, Hechtman L, Minde K, Iaboni-Kassab F (2003). The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Canadian Journal of Psychiatry 48, 546554.
Bron TI, Bijlenga D, Boonstra AM, Breuk M, Pardoen WFH, Beekman ATF, Kooij JJS (2014). OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study. European Neuropsychopharmacology 24, 519528.
Chamberlain SR, Robbins TW, Winder-Rhodes S, Müller U, Sahakian BS, Blackwell AD, Barnett JH (2011). Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biological Psychiatry 69, 11921203.
Coghill DR, Rhodes SM, Matthews K (2007). The neuropsychological effects of chronic methylphenidate on drug- naïve boys with attention-deficit/hyperactivity disorder. Biological Psychiatry 62, 954962.
Coghill DR, Seth S, Pedroso S, Usala T, Currie J, Gagliano A (2013). Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis. Biological Psychiatry 76, 603615.
Coons HW, Klorman R, Borgstedt AD (1987). Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder: II. Information processing. Journal of the American Academy of Child and Adolescent Psychiatry 26, 368374.
Cortese S, Kelly C, Chabernaud C, Proal E, Di Martino A, Milham MP, Castellanos FX (2012). Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. American Journal of Psychiatry 169, 10381055.
Cubillo A, Smith AB, Barrett N, Giampietro V, Brammer MJ, Simmons A, Rubia K (2014 a). Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naïve ADHD boys. Cerebral Cortex 24, 174185.
Cubillo A, Smith AB, Barrett N, Giampietro V, Brammer MJ, Simmons A, Rubia K (2014 b). Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory. Psychological Medicine 44, 633646.
DeVito EE, Blackwell AD, Clark L, Kent L, Dezsery AM, Turner DC, Aitken MRF, Sahakian BJ (2009). Methylphenidate improves response inhibition but not reflection impulsivity in children with attention deficit hyperactivity disorder (ADHD). Psychopharmacology 202, 531539.
DuPaul GJ, Barkley RA, McMurray MB (1994). Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. Journal of the American Academy of Child and Adolescent Psychiatry 33, 894903.
Durston S, Tottenham NT, Thomas KM, Davidson MC, Eigsti I-M, Yang Y, Ulug AM, Casey BJ (2003). Differential patterns of striatal activation in young children with and without ADHD. Biological Psychiatry 53, 871878.
Duval S, Tweedie R (2000). Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56, 455463.
Epstein JN, Brinkman WB, Froehlich T, Langberg JM, Narad ME, Antonini TN, Shiels K, Simon JO, Altaye M (2011). Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD. Neuropsychopharmacology 36, 10601072.
Epstein JN, Casey BJ, Tonev ST, Davidson MC, Reiss AL, Garrett A, Hinshaw SP, Greenhill LL, Glover G, Shafritz KM, Vitolo A, Kotler LA, Jarrett MA, Spicer J (2007). ADHD- and medication-related brain activation effects in concordantly affected parent–child dyads with ADHD. Journal of Child Psychology and Psychiatry 48, 899913.
Faraone SV, Biederman J (2006). What is the prevalence of adult ADHD? Results of a population screen of 966 adults. Journal of Attention Disorders 9, 384391.
Faraone SV, Buitelaar J (2010). Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. European Child and Adolescent Psychiatry 19, 353364.
Faraone SV, Glatt SJ (2010). A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. Journal of Clinical Psychiatry 71, 754763.
Frodl T, Skokauskas N (2012). Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatrica Scandinavica 125, 114126.
Giedd JN (2004). Structural magnetic resonance imaging of the adolescent brain. Annals of the New York Academy of Sciences 1021, 7785.
Gittelman R, Manuzza S, Shenker R, Bonagura N (1985). Hyperactive boys almost grown up I. Psychiatric status. Archives of General Psychiatry 42, 937947.
Gruber R, Grizenko N, Schwartz G, Bellingham J, Guzman R, Joober R (2007). Performance on the continuous performance test in children with ADHD is associated with sleep efficiency. Sleep 30, 10031009.
Günther T, Herpertz-Dahlmann B, Konrad K (2010). Sex differences in attentional performance and their modulation by methylphenidate in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 20, 179186.
Hanisch C, Konrad K, Günther T, Herpertz-Dahlmann B (2004). Age-dependent neuropsychological deficits and effects of methylphenidate in children with attention-deficit/hyperactivity disorder: a comparison of pre- and grade-school children. Journal of Neural Transmission 111, 865881.
Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K (2013). Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. Archives of General Psychiatry 70, 185198.
Higgins JPT, Green S (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration (www.cochrane-handbook.org).
Hozo SP, Djulbegovic B, Moore AN (2005). Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 5, 13.
Kavale K (1982). The efficacy of stimulant drug treatment for hyperactivity: a meta-analysis. Journal of Learning Disabilities 15, 280289.
Klorman R, Coons HW, Borgstedt AD (1987). Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder: I. Clinical findings. American Academy of Child and Adolescent Psychiatry 26, 363367.
Koda K, Ago Y, Cong Y, Takuma K, Matsuda T (2010). Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. Journal of Neurochemistry 114, 259270.
Konrad K, Günther T, Hanisch C, Herpertz-Dahlmann B (2004). Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 43, 191198.
Konrad K, Günther T, Heinzel-Gutenbrunner M, Herpertz-Dahlmann B (2005). Clinical evaluation of subjective and objective changes in motor activity and attention in children with attention-deficit/hyperactivity disorder in a double-blind methylphenidate trial. Journal of Child and Adolescent Psychopharmacology 15, 180190.
Kuczenski R, Segal DS (2002) Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. Journal of Neuroscience 22, 72647271.
Kuperman S, Perry P, Gaffney GR, Lund BC, Bever-Stille KA, Arndt S, Holman TL, Moser DJ, Paulsen JS (2001). Buproprion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. Annals of Clinical Psychiatry 13, 129134.
Lebel C, Gee M, Camicioli R, Wieler M, Martin W, Beaulieu C (2012). Diffusion tensor imaging of white matter tract evolution over the lifespan. NeuroImage 60, 340352.
Lipsey MW, Wilson DB (2001). Practical Meta-analysis, vol. 49. Sage Publications Inc.: Thousand Oaks, CA.
Loo SK, Hopfer C, Teale PD, Reite ML (2004). EEG correlates of methylphenidate response in ADHD: association with cognitive and behavioral measures. Journal of Clinical Neurophysiology 21, 457464.
Losier BJ, McGrath PJ, Klein RM (1996). Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. Journal of Child Psychology and Psychiatry 37, 971987.
Luman M, Papanikolau A, Oosterlaan J (2015). The unique and combined effects of reinforcement and methylphenidate on temporal information processing in attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology 35, 414421.
Manuzza S, Gittelman Klein R, Addalli KA (1991). Young adult mental status of hyperactive boys and their brothers: a prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry 30, 743751.
McInnes A, Bedard A, Hogg-Johnson S, Tannock R (2007). Preliminary evidence of beneficial effects of methylphenidate on listening comprehension in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 17, 3549.
Mehta MA, Goodyer IM, Sahakian BJ (2004). Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. Journal of Child Psychology and Psychiatry 45, 293305.
Milich R, Licht BG, Murphy DA, Pelham WE (1989). Attention-deficit hyperactivity disordered boys’ evaluations of and attributions for task performance on medication versus placebo. Journal of Abnormal Psychology 98, 280284.
Monden Y, Dan H, Nagashima M, Dan I, Tsuzuki D, Kyutoku Y, Gunji Y, Yamagata T, Watanabe E, Momoi MY (2012). Right prefrontal activation as a neuro-functional biomarker for monitoring acute effects of methylphenidate in ADHD children: an fNIRS study. NeuroImage. Clinical 1, 131140.
Monteiro Musten L, Firestone P, Pisterman S, Bennett S, Mercer J (1997). Effects of methylphenidate on preschool children with ADHD: cognitive and behavioral functions. Journal of the American Academy of Child and Adolescent Psychiatry 36, 14071415.
Morris SB, DeShon RP (2002). Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychological Methods 7, 105125.
Murray DW, Childress A, Giblin J, Williamson D, Armstrong R, Starr L (2011). Effects of OROS methylphenidate on academic, behavioural, and cognitive tasks in children 9 to 12 years of age with attention-deficit/hyperactivity disorder. Clinical Pediatrics 50, 308320.
Nakao T, Radua J, Rubia K, Mataix-Cols D (2011). Matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. American Journal of Psychiatry 168, 11541163.
Niculescu M, Ehrlich ME, Unterwald ME (2005). Age-specific behavioral responses to psychostimulants in mice. Pharmacological Biochemistry and Behavior 82, 280288.
Overtoom CCE, Bekker WM, van der Molen MW, Verbaten MN, Kooij JJS, Buitelaar JK, Kenemans JL (2009). Methylphenidate restores link between stop-signal sensory impact and successful stopping in adults with attention-deficit/hyperactivity disorder. Biological Psychiatry 65, 614619.
Overtoom CCE, Verbaten MN, Kemner C, Kenemans JL, van Engeland H, Buitelaar JK, van der Molen MW, van der Gugten J, Westenberg H, Maes RAA, Koelega HS (2003). Effects of methylphenidate, desipramine, and l-dopa on attention and inhibition in children with attention deficit hyperactivity disorder. Behavioural Brain Research 145, 715.
Pietrzak RH, Mollica CM, Maruff P, Snyder PJ (2006). Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. Neuroscience and Biobehavioral Reviews 30, 12251245.
Pliszka SR, Liotti M, Bailey BY, Perez R, Glahn D, Semrud-Clikeman M (2007). Electrophysiological effects of stimulant treatment on inhibitory control in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 17, 356366.
Punja S, Zorzela K, Hartling L, Urichuk L, Vohra S (2013). Long-acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacy. BMJ Open 3, e002312.
Ramtvedt BE, Røinås E, Aabech HS, Sundet KS (2013). Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials. Journal of Child and Adolescent Psychopharmacology 23, 597604.
Rhodes SM, Coghill DR, Matthews K (2004). Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder. Psychopharmacology 175, 319330.
Riccio CA, Waldrop JJM, Reynolds CR, Lowe P (2001). Effects of stimulants on the Continuous Performance Test (CPT) implications for CPT use and interpretation. Journal of Neuropsychiatry and Clinical Neuroscience 13, 326335.
Rosenthal R (1979). The ‘file drawer problem’ and tolerance for null results. Psychological Bulletin 85, 638641.
Rubia K, Alegria AA, Cubillo A, Smith AB, Brammer MJ, Radua J (2014). Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Biological Psychiatry 76, 616628.
Rubia K, Halari R, Cubillo A, Mohammad A, Brammer M, Taylor E (2009). Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task. Neuropharmacology 57, 640652.
Rubia K, Halari R, Mohammad A-M, Taylor E, Brammer M (2011) Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder. Biological Psychiatry 70, 255262.
Schachar R, Ickowicz A, Crosbie J, Donnelly GAE, Reiz JL, Miceli PC, Harsanyi Z, Darke AC (2008). Cognitive and behavioral effects of multilayer-release methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 18, 1124.
Scheres A, Oosterlaan J, Sergeant JA (2006). Speed of inhibition predicts teacher-rated medication response in boys with attention deficit hyperactivity disorder. International Journal of Disability, Development and Education 53, 93109.
Scheres A, Oosterlaan J, Swanson J, Morein-Zamir S, Meiran N, Schut H, Vlasveld L, Sergeant JA (2003). The effect of methylphenidate on three forms of response inhibition in boys with AD/HD. Journal of Abnormal Child Psychology 31, 105120.
Schwartz S, Correll CU (2014). Efficacy and safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression. Journal of the American Academy of Child and Adolescent Psychiatry 53, 174187.
Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch JP, Greenstein D, Clasen L, Evans A, Giedd J, Rapoport JL (2007). Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proceedings of the National Academy of Sciences 104, 1964919654.
Shaw P, Kabani NJ, Lerch JP, Eckstrand K, Lenroot R, Gogtay N, Greenstein D, Clasen L, Evans A, Rapoport JL, Giedd JN, Wise SP (2008). Neurodevelopmental trajectories of the human cerebral cortex. Journal of Neuroscience 28, 35863594.
Shiels K, Hawk LW Jr., Reynolds B, Mazzullo RJ, Rhodes JD, Pelham WE Jr., Waxmonsky JG, Gangloff BP (2009). Effects of methylphenidate on discounting of delayed rewards in attention deficit/hyperactivity disorder. Experimental and Clinical Psychopharmacology 17, 291301.
Simon V, Czobor P, Balint S, Mészarós Á, Bitter I (2009). Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. British Journal of Psychiatry 194, 204211.
Solanto M, Newcom J, Vail L, Gilbert S, Ivanov I, Lara R (2009). Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 19, 663671.
Solanto MV (1984). Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis. Psychological Bulletin 95, 387409.
Stein MA, Blondis TA, Schnitzler ER, O'Brien T, Fishkin J, Blackwell B, Szumowski E, Roizen NJ (1996). Methylphenidate dosing: twice daily versus three times daily. Pediatrics 98, 748756.
Sunohara GA, Malone MA, Rovet J, Humphries T, Roberts W, Taylor MJ (1999). Effect of methylphenidate on attention in children with attention deficit hyperactivity disorder (ADHD): ERP evidence. Neuropsychopharmacology 21, 218228.
Szobot CM, Ketzer C, Parente MA, Biederman J, Rohde LA (2004). The acute effect of methylphenidate in Brazilian male children and adolescents with ADHD: a randomized clinical trial. Journal of Attention Disorders 8, 3743.
Tamm L, Carlson CL (2007). Task demands interacts with the single and combined effects of medication and contingencies on children with ADHD. Journal of Attention Disorders 10, 372380.
Tannock R, Schachar R, Logan G (1995). Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children. Journal of Abnormal Child Psychology 23, 235266.
Toplak ME, West RF, Stanovich KE (2013). Practitioner review: do performance-based measures and ratings of executive function assess the same construct? Journal of Child Psychology and Psychiatry 54, 131143.
Tucha O, Prell S, Mecklinger L, Bormann-Kischkel C, Kübber S, Linder M, Walitza S, Lange KW (2006). Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder. Psychopharmacology 185, 315326.
Turner DC, Blackwell AD, Dowson JH, McLean A, Sahakian BJ (2005). Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder. Psychopharmacology 178, 286295.
Van der Oord S, Geurts HM, Prins PJM, Emmelkamp PMG, Oosterlaan J (2012). Prepotent response inhibition predicts treatment outcome in attention deficit/hyperactivity disorder. Child Neuropsychology 18, 5061.
Viechtbauer W (2010). Conducting meta-analyses in R with the metafor package. Journal of Statistical Software 36 (https://www.jstatsoft.org/article/view/v036i03/v36i03.pdf). Accessed February 2016.
Volkow ND, Wang G, Tomasi D, Kollins SH, Wigal TL, Newcorn JH, Telang FW, Fowler JS, Logan J, Wong CT, Swanson JM (2012). Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. Journal of Neuroscience 32, 841849.
Westlyle LT, Walhovd KB, Dale AM, Bjørnerud A, Due-Tønnessen P, Engvig A, Grydeland H, Tamnes CK, Østby Y, Fjell AM (2010). Life-span changes of the human brain white matter: diffusion tensor imaging (DTI) and volumetry. Cerebral Cortex 20, 20552068.
Wigal SB, Wigal T, Schuck S, Brams M, Williamson D, Armstrong RB, Starr L (2011). Academic, behavioral, and cognitive effects of OROS methylphenidate on older children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 21, 121131.
Wilson HK, Cox DJ, Merkel RL, Moore M, Coghill D (2006). Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with attention-deficit/hyperactivity disorder. Archives of Clinical Neuropsychology 21, 797807.
Zeiner P (1999). Do the beneficial effects of extended methylphenidate treatment in boys with attention-deficit hyperactivity disorder dissipate rapidly during placebo treatment? Nordic Journal of Psychiatry 53, 5560.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Type Description Title
WORD
Supplementary materials

Tamminga supplementary material
Appendix

 Word (307 KB)
307 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 24
Total number of PDF views: 191 *
Loading metrics...

Abstract views

Total abstract views: 860 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 16th January 2018. This data will be updated every 24 hours.